Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Closes Michrom Deal

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Bruker said today that it has closed its purchase of liquid chromatography company Michrom Bioresources for an undisclosed sum, and that it has moved its gas chromatography-mass spectrometry operations and headquarters from Walnut Creek, Calif. to Fremont, Calif.

Bruker said that Michrom's shareholders unanimously approved the deal. Michrom has been renamed Bruker-Michrom and will be run out of Auburn, Calif., where it was headquartered before the deal, and Bruker's Fremont offices.

Investments by Bruker will be directed toward development of Michrom's CaptiveSpray Ionization sources, HPLC systems, and related LC accessory, software, and consumables products.

All of Michrom's former employees have been offered positions at Bruker-Michrom, and Michrom founder Kerry Nugent has joined Bruker as senior vice president of liquid chromatography.

Bruker said that the acquisition of Michrom, which had around $3 million in revenue in 2010, would not have a material affect on its 2011 financials.

In a statement from Bruker when the Michrom deal was announced in February, Collin D'Silva, president of Bruker's Chemical and Applied Markets division, said the acquisition would provide the company's mass spec customers "with significant gains in throughput, sensitivity, and robustness for proteomics" applications.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.